Julie Maréchal-Jamil: Challenges for Biosimilars in Europe

Julie Maréchal-Jamil, director of biosimilars policy and science at Medicines for Europe, describes the challenges ahead for the European biosimilars market.
May 31, 2019


If I look at the market unfolding, let's say, I think one of the very important notions that needs to be reconciled is the short-term policy regarding budget management and the longer-term goal of healthcare equity and a greater quality of care because you can't forget that end goal and compromise it; you need to make sure you have thoughtful policies in place today so that you're not compromising meeting the big end goal.

I think this is essential and it has to do with a general education that competition in the pharmaceutical market is a dynamic and cyclic system, and for that, the time element is really important. It has to be seen in a bigger time frame than just the cycle of a call for tender or a purchasing bid, or this type of element.

For us, the challenge this year will be to make sure everybody in the healthcare community, from the makers to the end users, do have that time element to it. Yes there is “what's in it for me?” at every bit, but I think the time element will condition how deliverables are are actually happening or not, so this is really important.


Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars® is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2020 Intellisphere, LLC. All Rights Reserved.